<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200313046758N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-06-28</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Diabetic rehabilitation effect on type 2 diabetic patients and their family caregivers</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of diabetic rehabilitation on happiness and resilience of type 2 diabetic patients and their family caregivers, referring to diabetes clinics affiliated to Shiraz Medical Science University, in 1998-99</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-04-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>156</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/46513</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: The present study will be performed on type 2 diabetic patients and their family caregivers, Taking into account the drop of 10%, 39 patients and 39 family caregivers will be included in a total of 78 people in each of the intervention and control groups, Randomization description: Samples are first selected using the available sampling method using a 
random number table and according to the input criteria, then complete the questionnaires and random allocation using Random allocation software to generate a block randomization list, With the size of 4 blocks of 17 and 2 blocks of 5, a total of 6 blocks will be in two groups of intervention and control, which will be a total of 78 people, 39 people in the intervention group and 39 people in the control group, It should be noted that since the present study will be performed on the patient and his family caregiver, the patient's family caregiver will also be subject to intervention, taking into account the intervention group of 78 people, 39 patients plus 39 family caregivers, and the control group 78 A total of 156 people, 39 patients plus 39 family caregivers, will be included, Blinding description: Given that the questionnaires are distributed at all stages by the researcher and also the data analyzer will be unaware of the random allocation of 
groups to the intervention and control group, then the outcome assessor and data analyzer from the intervention and control groups they will not be aware.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Type 2 diabetic patients. Condition 2: Family caregivers of type 2 diabetic patients.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group, during 8 weeks and 8 face-to-face sessions will receive the rehabilitation program for diabetes, including introduction of diabetes education, treatment and its complications, foot care and self-control of blood sugar, nutrition and diet, exercise and amount of daily activity Individual, happiness training that includes, motivation and purpose, communicating with others and receiving support from them, being active, achieving, feeling positive and resilience training that includes, gaining self-awareness skills, positive thinking and optimism, problem-solving skills and anger management, crisis management and coping strategies, and the eighth session of diabetes management itself, which includes a summary of what has been said in previous sessions; And 8 times by phone, every 8 weeks after each training session Present and before the next meeting, based on the rehabilitation program and with the objectives of teaching, and if necessary, re-teaching the topics discussed in the face-to-face meetings, removing ambiguities and answering sample questions and remembering the time and place of the meeting The future will be and at the end of each session, educational pamphlets will be distributed. Intervention 2: Control group, will receive no intervention and will only receive the clinical care routine, training on diet and medication.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information is available</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Mahnaz Rakhshan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Fatemeh Nursing and Midwifery Faculty, Namazi Hospital, Namazi Square</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۳۱۱۹ - ۷۱۹۳۶</zip>
        <telephone>0098 7136474254-8</telephone>
        <email>rakhshanm@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Mahnaz Rakhshan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Fatemeh Nursing and Midwifery Faculty, Namazi Hospital, Namazi Square</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۳۱۱۹ - ۷۱۹۳۶</zip>
        <telephone>0098 7136474254-8</telephone>
        <email>rakhshanm@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of diabetes by a specialist
literacy
Patients and their family caregivers willingness and satisfaction with to participate in the study
Physical ability to travel to the clinic</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Failure to attend the training session for two consecutive sessions
Mental retardation and mental disorders
Unpleasant events for the samples during the study (such as losses and calamities that can aggravate distress or prevent participation in the intervention and continue cooperation in the study)
The incidence of sickness in the samples that causes them to be hospitalized and prevents them from participating in the intervention and continuing to work with the researcher</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E11</hc_code>
      <hc_code>E11</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Type 2 diabetes mellitus</hc_keyword>
      <hc_keyword>Type 2 diabetes mellitus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group, during 8 weeks and 8 face-to-face sessions will receive the rehabilitation program for diabetes, including introduction of diabetes education, treatment and its complications, foot care and self-control of blood sugar, nutrition and diet, exercise and amount of daily activity Individual, happiness training that includes, motivation and purpose, communicating with others and receiving support from them, being active, achieving, feeling positive and resilience training that includes, gaining self-awareness skills, positive thinking and optimism, problem-solving skills and anger management, crisis management and coping strategies, and the eighth session of diabetes management itself, which includes a summary of what has been said in previous sessions; And 8 times by phone, every 8 weeks after each training session Present and before the next meeting, based on the rehabilitation program and with the objectives of teaching, and if necessary, re-teaching the topics discussed in the face-to-face meetings, removing ambiguities and answering sample questions and remembering the time and place of the meeting The future will be and at the end of each session, educational pamphlets will be distributed</i_keyword>
      <i_keyword>Control group, will receive no intervention and will only receive the clinical care routine, training on diet and medication</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Happiness score. Timepoint: First time, before beginning the intervention, second time, at the end of the 8th session, third time, 5 weeks after the second time. Method of measurement: Oxford Happiness Questionnaire.</prim_outcome>
      <prim_outcome>Resiliency score. Timepoint: First time, before beginning the intervention, second time, at the end of the 8th session, third time, 5 weeks after the second time. Method of measurement: Conner and Davidson Resiliency scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-02-16</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Fatemeh Nursing and Midwifery Faculty, Namazi Hospital, Namazi Square Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
